Evidence map›Paper›PMID 23486222›Full record

ArticleOpen biology2013

Molecular mechanisms creating bistable switches at cell cycle transitions.

Anael Verdugo, P K Vinod, John J Tyson, Bela Novak

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cip1 tunes cell cycle arrest duration upon calcineurin activation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Eternal sunshine of the spotless cycle.Molecular systems biology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Anael VerdugoDepartment of Biochemistry, University of Oxford, Oxford, UK.
P K Vinod
John J Tyson
Bela Novak
University of Oxford · GBVirginia Tech · US

Funding

Novel Targets in Endocrine ResponsivenessU54CA149147 · NCI · GEORGETOWN UNIVERSITY · PI CLARKE, ROBERT R. · 2010 to 2014
$6.9M
Stochastic Models of Cell Cycle Regulation in EukaryotesR01GM078989 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI PECCOUD, JEAN M, TYSON, JOHN J. · 2006 to 2018
$5.3M
Biotechnology and Biological Sciences Research CouncilNCI NIH HHS U54 CA149147NIGMS NIH HHS 5R01GM078989-06NIGMS NIH HHS R01 GM078989
6 · The paper itself

Abstract

Progression through the eukaryotic cell cycle is characterized by specific transitions, where cells move irreversibly from stage i-1 of the cycle into stage i. These irreversible cell cycle transitions are regulated by underlying bistable switches, which share some common features. An inhibitory protein stalls progression, and an activatory protein promotes progression. The inhibitor and activator are locked in a double-negative feedback loop, creating a one-way toggle switch that guarantees an irreversible commitment to move forward through the cell cycle, and it opposes regression from stage i to stage i-1. In many cases, the activator is an enzyme that modifies the inhibitor in multiple steps, whereas the hypo-modified inhibitor binds strongly to the activator and resists its enzymatic activity. These interactions are the basis of a reaction motif that provides a simple and generic account of many characteristic properties of cell cycle transitions. To demonstrate this assertion, we apply the motif in detail to the G1/S transition in budding yeast and to the mitotic checkpoint in mammalian cells. Variations of the motif might support irreversible cellular decision-making in other contexts.

Indexed as

Models, MolecularCell CycleCyclin-Dependent Kinase Inhibitor ProteinsCyclin-Dependent KinasesEnzymesG1 PhaseKineticsSaccharomyces cerevisiaeSubstrate SpecificityCyclin-Dependent Kinase Inhibitor ProteinsCyclin-Dependent KinasesEnzymes

Identifiers

PMID23486222
PMCPMC3718337
OpenAlexW2023608437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.